Publicaciones
El conocimiento generado en IrsiCaixa se comparte con la comunidad científica a través de la publicación de artículos en revistas científicas de alto impacto.
![Imatge de Publicacions](/sites/default/files/styles/3_1_small/public/2022-11/Portada_publicacions-petita_0.jpg?h=c6980913&itok=oZMso2V6)
Effect of α-Methoxy Substitution on the Anti-HIV Activity of Dihydropyrimidin-4(3 H)-ones.
Incidence of cervical high-grade squamous intraepithelial lesions in HIV-1-infected women with no history of cervical pathology: up to 17 years of follow-up.
ADAR1 affects HCV infection by modulating innate immune response.
CD32 expression is associated to T-cell activation and is not a marker of the HIV-1 reservoir.
Antiviral treatment strategies based on gene silencing and genome editing.
Evaluation of the Innate Immune Modulator Acitretin as a Strategy To Clear the HIV Reservoir.
Chiral Indolylarylsulfone Non-Nucleoside Reverse Transcriptase Inhibitors as New Potent and Broad Spectrum Anti-HIV-1 Agents.
SAMHD1 is active in cycling cells permissive to HIV-1 infection.
RNA editing by ADAR1 regulates innate and antiviral immune functions in primary macrophages.
Human DDX3 protein is a valuable target to develop broad spectrum antiviral agents.